RxDoctor Payments Data

Flint Walker, DO

Family Medicine · Hilton Head, SCNPI 1215356894

Payments from drug & device makers

$1,666in general payments, 2019–2025

Across 92 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$290
  • Pfizer$219
  • AstraZeneca$183
  • AbbVie$145
  • Amarin Pharma, Inc.$140
  • Lilly USA, LLC$108
  • plus $582 from 15 others

What the payments were for

  • Food & beverage$1,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,666 in reported general payments places this provider in the 70th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$289,824
Medicare patients
401
Services billed
3,045

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide131$138,430
EliquisApixaban139$132,831
JardianceEmpagliflozin40$55,690
Repatha SureclickEvolocumab49$44,971
MounjaroTirzepatide35$34,426
JanuviaSitagliptin Phosphate33$31,590
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$25,797
MyrbetriqMirabegron19$20,702
LinzessLinaclotide14$17,530
TradjentaLinagliptin21$16,583
Breo ElliptaFluticasone/Vilanterol20$13,157
GemtesaVibegron20$11,782
NamzaricMemantine Hcl/Donepezil Hcl16$9,279
XareltoRivaroxaban11$9,055
Icosapent Ethyl12$6,878

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$290$138,430131 claims
PfizerEliquis, Paxlovid$219$134,265186 claims
Boehringer IngelheimJardiance, Tradjenta$103$72,27361 claims
GSKTrelegy Ellipta, Breo Ellipta$75$38,95546 claims
Lilly USA, LLCMounjaro$108$34,42635 claims
MerckJanuvia$65$31,59033 claims
AbbVieLinzess, Namzaric, Synthroid$145$29,01463 claims
Astellas Pharma US IncMyrbetriq$16$20,70219 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Hilton Head

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →